Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: A pilot study

European Neuropsychopharmacology

Volumn 26, Issue 1, 2016, Pages 37-44

  Terraneo, Alberto ^a   Leggio, Lorenzo ^b,c,d   Saladini, Marina ^e   Ermani, Mario ^e   Bonci, Antonello ^b,f   Gallimberti, Luigi ^a  

^a IRCCS SAN CAMILLO HOSPITAL   (Italy)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF PADOVA   (Italy)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Cocaine use disorder; Craving; Optogenetics; Prefrontal cortex; Repeated transcranial magnetic stimulation

Indexed keywords

COCAINE; DISULFIRAM; DOPAMINE UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION SYSTEM; TREATMENT OUTCOME; TREATMENT RESPONSE; URINALYSIS; WITHDRAWAL SYNDROME; ADVERSE EFFECTS; COCAINE-RELATED DISORDERS; CRAVING; FOLLOW UP; KAPLAN MEIER METHOD; PATHOPHYSIOLOGY; PILOT STUDY; PREFRONTAL CORTEX; PROCEDURES; PSYCHOLOGY; URINE;

ADULT; COCAINE; COCAINE-RELATED DISORDERS; CRAVING; DEPRESSION; DOPAMINE UPTAKE INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PILOT PROJECTS; PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84959077235     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.11.011     Document Type: Article

References (49)

1. Ansseau M., Papart P., Gérard M.A., von Frenckell R., Franck G. Controlled comparison of buspirone and oxazepam in generalized anxiety. Neuropsychobiology 1990, 24(2):74-78.
2. Balleine B.W., Dickinson A. Goal-directed instrumental action: contingency and incentive learning and their cortical substrates. Neuropharmacology 1998, 37(4):407-419.
3. Barker A.T., Jalinous R., Freeston I.L. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985, 1:1106-1107.
4. Barr M.S., Farzan F., Wing V.C., George T.P., Fitzgerald P.B., Daskalakis Z.J. Repetitive transcranial magnetic stimulation and drug addiction. Int. Rev. Psychiatry 2011, 23(5):454-466.
5. Bech P., Bille J., Møller S.B., Hellström L.C., Østergaard S.D. Psychometric validation of the Hopkins symptom checklist (SCL-90) subscales for depression, anxiety, and interpersonal sensitivity. J. Affect. Disord. 2014, 160:98-103.
6. Camprodon J.A., Martínez-Raga J., Alonso-Alonso M., Shih M., Pascual-Leone A. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug. Alcohol Depend. 2007, 86(1):91-94.
7. Chen B.T., Yau H., Hatch C., Kusumoto-Yoshida I., Cho S.L., Hopf F.W., Bonci A. Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking. Nature 2013, 496(7445):359-362.
8. Chen R., Classen J., Gerloff C., Celnik P., Wassermann E., Hallett M., Cohen L. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997, 48(5):1398-1403.
9. Cho S.S., Strafella A.P. rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLOS One 2009, 4:e6725.
10. Cohen L.G., Roth B.J., Nilsson J., Dang N., Panizza M., Bandinelli S., Friauf W., Hallett M. Effects of coil design on delivery of focal magnetic stimulation. Technical considerations. Electroencephalogr. Clin. Neurophysiol. 1990, 75(4):350-357.
11. Conti C.L., Nakamura-Palacios E.M. Bilateral transcranial direct current stimulation over dorsolateral prefrontal cortex changes the drug-cued reactivity in the anterior cingulate cortex of crack-cocaine addicts. Brain Stimul. 2014, 7(1):130-132.
12. Corrigan M.H., Denahan A.Q., Wright C.E., Ragual R.J., Evans D.L. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depression Anxiety 2000, 11(2):58-65.
13. Daskalakis Z.J., Moller B., Christensen B.K., Fitzgerald P.B., Gunraj C., Chen R. The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp. Brain Res. 2006, 174:403-412.
14. Lazzaro Di, Ziemann V., Lemon RN U. State of the art: physiology of transcranial motor cortex stimulation. Brain Stimul. 2008, 1(4):345-362.
15. European Monitoring Centre for Drugs and Drug Addiction Annual Overview of the European Drug Situation on 27 May in a Multilingual, Multimedia Information Package Focusing on Today's Rapidly Shifting Drug Phenomenon, EMCDDA 2014.
16. Gass J., Chandler L. The plasticity of extinction: contribution of the prefrontal cortex in treating addiction through inhibitory learning. Front. Psychiatry 2013, 4:46.
17. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159(10):1642-1652.
18. Goldstein R.Z., Volkow N.D. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 2011, 12(11):652-669.
19. Hatzigiakoumis D.S., Martinotti G., Giannantonio M.D., Janiri L. Anhedonia and substance dependence: clinical correlates and treatment options. Front. Psychiatry 2011, 2:10.
20. Holroyd C.B., Coles M.G. The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol. Rev. 2002, 109(4):679.
21. Jasinska A.J., Chen B.T., Bonci A., Stein E.A. Dorsal medial prefrontal cortex (MPFC) circuitry in rodent models of cocaine use: implications for drug addiction therapies. Addict. Biol. 2014, 20(2):215-226.
22. Karila L., Gorelick D., Weinstein A., Noble F., Benyamina A., Coscas S., et al. New treatments for cocaine dependence: a focused review. Int. J. Neuropsychopharmacol. 2008, 11(3):425-438.
23. Kaufman J.N., Ross T.J., Stein E.A., Garavan H. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J. Neurosci.: Off. J. Soc. Neurosci. 2003, 23(21):7839-7843.
24. Ke Y., Streeter C.C., Nassar L.E., Sarid-Segal O., Hennen J., Yurgelun-Todd D.A., et al. Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res.: Neuroimaging 2004, 130(3):283-293.
25. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35(1):217-238.
26. Lefaucheur J., André-Obadia N., Antal A., Ayache S.S., Baeken C., Benninger D.H., De Ridder D. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin. Neurophysiol. 2014, 125(11):2150-2206.
27. Licata S.C., Renshaw P.F. Neurochemistry of drug action. Ann. N. Y. Acad. Sci. 2010, 1187(1):148-171.
28. Lipman R.S. Depression scales derived from the Hopkins symptom checklist. Assessment of Depression 1986, 232-248. Springer, Berlin. N. Sartorius, T. Ban (Eds.).
29. Mah L., Zarate C.A., Nugent A.C., Singh J.B., Manji H.K., Drevets W.C. Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression. Int. J. Neuropsychopharmacol. 2011, 14(4):545-551.
30. Mamelak M., Scharf M.B., Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 1985, 9(1 Pt 2):285-289.
31. Matochik J.A., London E.D., Eldreth D.A., Cadet J., Bolla K.I. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 2003, 19(3):1095-1102.
32. McDonnell M.N., Orekhov Y., Ziemann U. The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp. Brain Res. 2006, 173:86-93.
33. Milby J.B., Conti K., Wallace D., Mennemeyer S., Mrug S., Schumacher J.E. Comorbidity effects on cocaine dependence treatment and examination of reciprocal relationships between abstinence and depression. J. Consult. Clin. Psychol. 2015, 83:45-55.
34. Moreno-López L., Catena A., Fernández-Serrano M.J., Delgado-Rico E., Stamatakis E.A., Pérez-García M., Verdejo-García A. Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals. Drug. Alcohol Depend. 2012, 125(3):208-214.
35. Pani P.P., Trogu E., Vecchi S., Amato L. Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database Syst. Rev. 2011, 7(12).
36. Pakes G.E., Brogden R.N., Heel R.C., Speight T.M., Avery G.S. Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 1981, 22(2):81-110.
37. Papaleo F., Yang F., Garcia S., Chen J., Lu B., Crawley J., Weinberger D. Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol. Psychiatry 2012, 17(1):85-98.
38. Pascual-Leone A., Valls-Sole J., Wassermann E., Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 1994, 117(Pt 4):847-858.
39. Politi E., Fauci E., Santoro A., Smeraldi E. Daily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine craving. Am. J. Addict. 2008, 17(4):345-346.
40. Reimherr F.W., Cunningham L.A., Batey S.R., Johnston J.A., Ascher J.A. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients. Clin. Ther. 1998, 20(3):505-516.
41. Roy É., Jutras-Aswad D., Bertrand K., Dufour M., Perreault M., Laverdière É., Bene-Tchaleu F., Bruneau J. Anxiety, mood disorders and injection risk behaviors among cocaine users: results from the COSMO study. Am. J. Addict. 2015, 24(7):654-660.
42. Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 2009, 120(12):2008-2039.
43. Strafella A.P., Paus T., Barrett J., Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J. Neurosci. 2001, 21:RC157.
44. Suh J.J., Pettinati H.M., Kampman K.M., O'Brien C.P. The status of disulfiram: a half of a century later. J. Clin. Psychopharmacol. 2006, 26(3):290-302.
45. Terao Y., Ugawa Y. Basic mechanisms of TMS. J. Clin. Neurophysiol. 2002, 19:322-343.
46. Volkow N.D., Fowler J.S., Wang G., Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 2004, 9(6):557-569.
47. Volkow N.D., Fowler J.S., Wang G., Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 2004, 9(6):557-569.
48. Volkow N.D., Fowler J.S., Wang G.J. The addicted human brain: Insights from imaging studies. J. Clin. Investig. 2003, 111(10):1444-1451.
49. Ziemann U., Hallett M. Basic neurophysiological studies with TMS. Transcranial Magnetic Stimulation in Neuropsychiatry. 2000, 45. American Psychiatric Press, Washington, DC.